DXA is a non-invasive procedure requiring minimal radiation that can be used alongside plain radiography to quantify the regenerate.
The procedure required minimal experimenter involvement, and the participants could complete the ratings using any computer with Internet access.
This process requires minimal manual intervention.
There are two commonly used methods for assessing the level of consciousness of a patient: a simple procedure that requires minimal training, and a more complex procedure that requires substantial expertise.
To date, qRT-PCR is the method of validation that has been used in the majority of published microarray studies, presumably because it is a rapid, sensitive, high throughput procedure that requires minimal amounts of test material compared to techniques such as Northern blotting or ribonuclease protection assays.
The essential benefits of the procedure are that it requires minimal input data that can be obtained from simple fragmentation tests, and that the procedure is computationally efficient enabling application to large scale industrial structures.
The procedure is practical, affordable, and requires minimal technical skills.
While guaranteeing stability, the proposed procedure is optimized for accuracy and requires minimal algorithmic modifications to already existing schemes.
We can conclude that the LGPBP could be used as an implant for VC medialization because it is biocompatible, readily available, easy to handle and remove during surgical procedures, nonabsorbable, and nonmigrant or extrudable, requires minimal preparation, and produces a similar inflammatory reaction to that of PTFE and PET.
Lymph node aspirates are simple to obtain, and the procedure is cheap and safe with limited risks, as it is less invasive and requires minimal instrumentation.
